The US Court of Appeals this week reinstated a suit from LifeWatch (SWX:LIFE) Services claiming that Blue Cross Blue Shield and associated plans conspired to deny coverage to devices it produces. LifeWatch claims that BCBS and associated groups “shielded themselves from patient demand for the seller’s device by agreeing to deny coverage as ‘not medically necessary’ […]
LifeWatch
7 medtech stories we missed this week: April 14, 2017
From FDA approvals to business expansion plans, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer […]
